Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.580
-0.070 (-4.24%)
At close: Jun 15, 2026, 4:00 PM EDT
1.720
+0.140 (8.86%)
After-hours: Jun 15, 2026, 6:38 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $11.38 million as of June 15, 2026. Its market cap has decreased by -55.03% in one year.
Market Cap
11.38M
Enterprise Value
3.84M
1-Year Change
-55.03%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $11.38M, a decrease of -98.20%. That is a compound annual growth rate of -53.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 11.38M | 12.02% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 13.65M |
| CytoMed Therapeutics | 13.49M |
| OSR Holdings | 13.38M |
| Jasper Therapeutics | 12.81M |
| Phio Pharmaceuticals | 12.43M |
| BioVie | 12.29M |
| SeaStar Medical Holding | 11.98M |
| Cadrenal Therapeutics | 11.39M |